Physician, known for his patient work at Sharp HealthCare, also helped found key cancer research center. He died Dec. 1 at ...

Genesis is entering the WEC’s Hypercar class next year with a pair of GMR-001 Hypercars but, with the Qatar curtain-raiser being a longer ten-hour maximum event, it will field three drivers in each ...

Most drugs withdrawn from the market because of serious toxicities never make it back. But Biogen Idec succeeded in getting its multiple sclerosis (MS) drug Tysabri reintroduced in less than 16 months ...

Cyril Abiteboul looks back on a remarkable 2025 for Genesis Magma Racing as the team has developed both the GMR-001 Hypercar ...

Illinois Department of Early ChildhoodKathleen Carolyn "KC" Stralka will serve as the Assistant Secretary of Project ...

The Genesis brand wants to prove itself in endurance racing. Genesis, the luxury brand nested under Hyundai, will join the list of automotive brands hoping to capitalize on the marketing phenomenon of ...

Charles Weissmann, molecular biologist, Biogen co-founder and alpha interferon cloner, has died at 94. Here's how he shaped ...

Royalty Pharma has acquired PTC's remaining royalty on Roche's Evrysdi for $240 million upfront and sales-based milestones.

MND patients in the UK denied access to lifesaving drug tofersen, despite Biogen supplying it free, due to NHS covering ...

The Prognostic Lung Fibrosis Consortium (PROLIFIC), a collaborative consortium advancing biomarker tools for pulmonary fibrosis (PF) research, announced today that the PROLIFIC Risk Score has been ...